Arkolith/Insider Trading/LEXX/Form 4/A

Downey Gregory

Chief Financial OfficerLexaria Bioscience Corp. (LEXX) · full profile →Form 4/A · filed Oct 18, 2022
Net Buying
Open-Market Buys
$253
Open-Market Sells
$0
Net Open-Market Flow
$253
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 14, 2022Buy(P)121$2.09$2532K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001855763-22-000020) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML